data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Verona Pharma
(NASDAQ:VRNA)
$13.26
-0.31[-2.28%]
At close: Dec 6(Delayed 15-Minutes)
Get Real Time Here
$13.26
After Hours: 4:00PM EDT
Day Range13.18 - 13.8152 Wk Range3.41 - 14.69Open / Close13.38 / 13.26Float / Outstanding52.6M / 75.6M
Vol / Avg.225.8K / 236.8KMkt Cap1BP/E-50d Avg. Price11.5
Div / Yield-Payout Ratio-Total Float52.6MEPS-0.24

Verona Pharma Stock (NASDAQ:VRNA), Quotes and News Summary

Verona Pharma Stock (NASDAQ: VRNA) stock price, news, charts, stock research, profile.

Day Range13.18 - 13.8152 Wk Range3.41 - 14.69Open / Close13.38 / 13.26Float / Outstanding52.6M / 75.6M
Vol / Avg.225.8K / 236.8KMkt Cap1BP/E-50d Avg. Price11.5
Div / Yield-Payout Ratio-Total Float52.6MEPS-0.24
Christopher Sappo - Sep 22, 2022, 11:06AM
Vandana Singh - Aug 29, 2022, 2:48PM
Globe Newswire - Nov 9, 2022, 2:00AM
Globe Newswire - Nov 2, 2022, 3:00AM
Globe Newswire - Oct 26, 2022, 2:00AM
Globe Newswire - Oct 17, 2022, 2:00AM
Globe Newswire - Oct 14, 2022, 2:00AM
Globe Newswire - Aug 29, 2022, 2:00AM
PRNewswire - Aug 26, 2022, 8:35AM
Globe Newswire - Aug 24, 2022, 2:00AM
Globe Newswire - Aug 19, 2022, 2:46AM
Globe Newswire - Aug 15, 2022, 4:05PM
Globe Newswire - Aug 10, 2022, 8:22PM
Globe Newswire - Aug 9, 2022, 4:16PM
PRNewswire - Aug 9, 2022, 9:04AM
Globe Newswire - Aug 9, 2022, 3:00AM
Globe Newswire - Aug 9, 2022, 2:00AM
Globe Newswire - Aug 8, 2022, 4:30PM
Globe Newswire - Jul 29, 2022, 2:00AM
PRNewswire - Jul 13, 2022, 11:30AM
Globe Newswire - Jun 9, 2022, 2:00AM
Globe Newswire - Jun 6, 2022, 2:00AM
Globe Newswire - May 25, 2022, 2:00AM
Globe Newswire - May 9, 2022, 2:00AM
Globe Newswire - May 4, 2022, 2:00AM
Globe Newswire - May 3, 2022, 2:00AM
Globe Newswire - Apr 19, 2022, 2:00AM
Globe Newswire - Mar 14, 2022, 3:00AM
Globe Newswire - Mar 3, 2022, 2:00AM
Globe Newswire - Feb 17, 2022, 2:00AM
Globe Newswire - Jan 24, 2022, 2:00AM
Globe Newswire - Jan 5, 2022, 2:00AM
Globe Newswire - Jan 4, 2022, 2:00AM
Globe Newswire - Dec 16, 2021, 2:00AM
TalkMarkets - Nov 25, 2022, 6:40PM
TalkMarkets - Nov 25, 2022, 6:31PM
Seeking Alpha - Nov 23, 2022, 8:55PM
InvestorsObserver - Nov 23, 2022, 2:11PM
TipRanks - Nov 14, 2022, 6:40AM
TipRanks - Nov 10, 2022, 6:55AM
Seeking Alpha - Nov 9, 2022, 2:04PM
Seeking Alpha - Nov 9, 2022, 2:33AM
TipRanks - Nov 6, 2022, 7:00PM
InvestorsObserver - Oct 31, 2022, 12:01PM
Seeking Alpha - Oct 27, 2022, 12:00PM
Seeking Alpha - Oct 27, 2022, 12:00PM
TipRanks - Oct 19, 2022, 10:45AM
TipRanks - Oct 17, 2022, 6:31AM
TipRanks - Oct 14, 2022, 12:45PM
Seeking Alpha - Oct 14, 2022, 5:59AM
InvestorsObserver - Sep 28, 2022, 12:46PM
TipRanks - Sep 19, 2022, 6:45AM
Seeking Alpha - Sep 13, 2022, 5:02AM
TipRanks - Aug 29, 2022, 6:25AM
InvestorsObserver - Aug 25, 2022, 3:14PM
Seeking Alpha - Aug 19, 2022, 5:20AM
TipRanks - Aug 18, 2022, 9:13AM
InvestorsObserver - Aug 15, 2022, 3:13PM
InvestorsObserver - Aug 11, 2022, 9:43AM
Seeking Alpha - Aug 11, 2022, 4:25AM
InvestorsObserver - Aug 10, 2022, 6:53AM
TipRanks - Aug 9, 2022, 3:10PM
InvestorsObserver - Aug 9, 2022, 2:20PM
TalkMarkets - Aug 9, 2022, 12:35PM
InvestorPlace - Aug 9, 2022, 11:27AM
InvestorPlace - Aug 9, 2022, 11:10AM
InvestorPlace - Aug 9, 2022, 10:56AM
InvestorPlace - Aug 9, 2022, 10:38AM
Seeking Alpha - Aug 9, 2022, 10:18AM
Sector: Health Care.Industry: Pharmaceuticals
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
Read More

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-02
REV
Q3 2022Est.ActualSurprise
EPS-0.160-0.230 -0.0700
REV3.570M0-3.570M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Verona Pharma (VRNA) stock?

A

You can purchase shares of Verona Pharma (NASDAQ: VRNA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Verona Pharma's (VRNA) competitors?

Q

What is the target price for Verona Pharma (VRNA) stock?

A

The latest price target for Verona Pharma (NASDAQ: VRNA) was reported by HC Wainwright & Co. on Monday, August 29, 2022. The analyst firm set a price target for 30.00 expecting VRNA to rise to within 12 months (a possible 126.24% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Verona Pharma (VRNA)?

A

The stock price for Verona Pharma (NASDAQ: VRNA) is $13.26 last updated Today at December 6, 2022, 9:00 PM UTC.

Q

Does Verona Pharma (VRNA) pay a dividend?

A

There are no upcoming dividends for Verona Pharma.

Q

When is Verona Pharma (NASDAQ:VRNA) reporting earnings?

A

Verona Pharma’s Q4 earnings are confirmed for Thursday, March 2, 2023.

Q

Is Verona Pharma (VRNA) going to split?

A

There is no upcoming split for Verona Pharma.

Q

What sector and industry does Verona Pharma (VRNA) operate in?

A

Verona Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.